Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA 4715 (miR-4715, hsa-miR-4715-3p) is a small, non-coding RNA molecule classified as a microRNA, typically composed of 21–23 nucleotides. Like other microRNAs, it functions primarily by binding complementary sequences on specific messenger RNAs, mediating post-transcriptional gene silencing through inhibition of translation or degradation of the target mRNA. Recent studies have implicated miR-4715-3p in the modulation of immune cell processes, particularly macrophage infiltration and pyroptosis, through a regulatory axis with the protein Gasdermin D during the progression of nonalcoholic fatty liver disease (NAFLD). Its role as a disease biomarker is emerging in liver fibrosis, although there is only limited evidence so far for this specific microRNA in other diseases such as cancer. As a microRNA, miR-4715 is not classified as a receptor, enzyme, transporter, or typical drug target, but instead is a regulatory RNA molecule.
Small RNA-induced silencing, typically through binding to the 3' UTR of messenger RNA to suppress translation or promote mRNA decay
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 4715 (miR-4715).